Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Jun;28(6):1120–1124. doi: 10.1128/jcm.28.6.1120-1124.1990

Pneumonia caused by a newly recognized pseudomonad in a child with chronic granulomatous disease.

J A Trotter 1, T L Kuhls 1, D A Pickett 1, S Reyes de la Rocha 1, D F Welch 1
PMCID: PMC267888  PMID: 2380349

Abstract

A pseudomonad was isolated from the pleural fluid and pulmonary decortication tissue of a 5-year-old child with chronic granulomatous disease. Although the isolate was phenotypically similar to Pseudomonas cepacia, its biochemical profile was more similar to that of Pseudomonas pickettii biovar 2. Its slow growth rate, ability to hydrolyze urea rapidly, and lateral and polar flagellar pattern were suggestive of Oligella ureolytica (formerly CDC group IVe). The cellular fatty acid composition was similar to that of P. cepacia and Pseudomonas gladioli, except for the presence of dodecanoic acid. Numerical analysis of the fatty acid data supported the interrelatedness of the isolate with other species of the pseudomallei group (rRNA homology group II) of Pseudomonas. The organism described in this report is an addition to the growing list of catalase-positive organisms which can potentially cause severe morbidity in patients with chronic granulomatous disease.

Full text

PDF
1120

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bottone E. J., Douglas S. D., Rausen A. R., Keusch G. T. Association of Pseudomonas cepacia with chronic granulomatous disease. J Clin Microbiol. 1975 May;1(5):425–428. doi: 10.1128/jcm.1.5.425-428.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Christenson J. C., Welch D. F., Mukwaya G., Muszynski M. J., Weaver R. E., Brenner D. J. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis. J Clin Microbiol. 1989 Feb;27(2):270–273. doi: 10.1128/jcm.27.2.270-273.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dees S. B., Hollis D. G., Weaver R. E., Moss C. W. Cellular fatty acid composition of Pseudomonas marginata and closely associated bacteria. J Clin Microbiol. 1983 Nov;18(5):1073–1078. doi: 10.1128/jcm.18.5.1073-1078.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Moss C. W., Dees S. B. Cellular fatty acids and metabolic products of Pseudomonas species obtained from clinical specimens. J Clin Microbiol. 1976 Dec;4(6):492–502. doi: 10.1128/jcm.4.6.492-502.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mukwaya G. M., Welch D. F. Subgrouping of Pseudomonas cepacia by cellular fatty acid composition. J Clin Microbiol. 1989 Dec;27(12):2640–2646. doi: 10.1128/jcm.27.12.2640-2646.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. O'Neil K. M., Herman J. H., Modlin J. F., Moxon E. R., Winkelstein J. A. Pseudomonas cepacia: an emerging pathogen in chronic granulomatous disease. J Pediatr. 1986 Jun;108(6):940–942. doi: 10.1016/s0022-3476(86)80934-9. [DOI] [PubMed] [Google Scholar]
  7. Rotrosen D., Gallin J. I. Disorders of phagocyte function. Annu Rev Immunol. 1987;5:127–150. doi: 10.1146/annurev.iy.05.040187.001015. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES